James Schoeneck

James Schoeneck

Chairman at KYNTRA BIO, INC.

Net worth: 289 330 $ as of 2026-05-30

68 year
Health Technology
Consumer Services
Commercial Services

Profile

James A. Schoeneck is a businessperson who has been at the head of 5 different companies. Presently, Mr. Schoeneck holds the position of Chairman of FibroGen, Inc. He is also on the board of Calidi Biotherapeutics, Inc. In his past career James A. Schoeneck occupied the position of Chief Executive Officer of BrainCells, Inc., President, Chief Executive Officer & Director at Assertio Therapeutics, Inc., Chief Executive Officer of ActivX Biosciences, Inc., President, Chief Executive & Operating Officer at Prometheus Laboratories, Inc., Vice President & General Manager-Immunology at Centocor, Inc., Principal at KYORIN Pharmaceutical Co., Ltd. and Director-Marketing & Product Group at Rhone-Poulenc Rorer, Inc. James A. Schoeneck received an undergraduate degree from Jacksonville State University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-06-11 39,666 ( 0.98% ) 273 695 $ 2026-05-30
2026-04-16 84,514 ( 2.36% ) 15 635 $ 2026-05-30

James Schoeneck active positions

CompaniesPositionStart
KYNTRA BIO, INC. Chairman 2020-01-05
CALIDI BIOTHERAPEUTICS, INC. Chairman 2025-03-31
CONNECT BIOPHARMA HOLDINGS LIMITED Director/Board Member 2025-07-21
Director/Board Member 2020-06-30

Former positions of James Schoeneck

CompaniesPositionEnd
ANAPTYSBIO, INC. Director/Board Member 2018-03-18
Chief Executive Officer 2017-03-27
Chief Executive Officer 2010-12-31
Chief Executive Officer 2004-11-30
Chief Executive Officer 2002-12-31
See the detail of James Schoeneck's experience

Training of James Schoeneck

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

60

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. James Schoeneck
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!